CN109303789B - Cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity, and its preparation method and application - Google Patents

Cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity, and its preparation method and application Download PDF

Info

Publication number
CN109303789B
CN109303789B CN201710628457.0A CN201710628457A CN109303789B CN 109303789 B CN109303789 B CN 109303789B CN 201710628457 A CN201710628457 A CN 201710628457A CN 109303789 B CN109303789 B CN 109303789B
Authority
CN
China
Prior art keywords
prolyl
cornu cervi
cervi pantotrichum
endonuclease
active component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710628457.0A
Other languages
Chinese (zh)
Other versions
CN109303789A (en
Inventor
靳艳
叶明亮
于洋
晏嘉泽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN201710628457.0A priority Critical patent/CN109303789B/en
Publication of CN109303789A publication Critical patent/CN109303789A/en
Application granted granted Critical
Publication of CN109303789B publication Critical patent/CN109303789B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a preparation method and application of a pilose antler active component with prolyl endonuclease inhibition activity. The invention takes the pilose antler as the raw material, establishes the preparation method of the pilose antler active component with prolyl endonuclease inhibition activity, and the active component can be applied to the prevention and treatment of cognitive disorder diseases such as Alzheimer disease and the like, and has wide application prospect.

Description

Cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity, and its preparation method and application
Technical Field
The invention relates to a preparation method and application of a pilose antler active component with prolyl endonuclease inhibitory activity, wherein the pilose antler active component with the prolyl endonuclease inhibitory activity can be used for treating or preventing neurodegenerative diseases such as cognitive impairment diseases such as Alzheimer's disease, Parkinson's disease and the like.
Background
Cornu Cervi Pantotrichum is unrossified young horn of male deer dense villus of Cervidae Cervus Nippon Temminck or Cervus Elaphus L, which has been recorded in Shen nong Ben Cao Jing of Han Dynasty for over 2000 years, and has been accepted in the herbal medicine of all the generations. The compendium of materia medica records that pilose antler can 'produce essence and supplement marrow, nourish blood and benefit yang, strengthen tendons and bones, treat all deficiency, deafness, dim eyesight, vertigo and deficiency dysentery' (document 1: Jijing, Qianjing, Huangfengjie, etc.. research on active substances and pharmacological actions of pilose antler, Chinese Journal of Biochemical pharmaceuticals, 2009,30(2): 141-143).
Prolyl Endopeptidase (PEP), also known as Prolyl oligopeptidase, is a high retention serine protease. PEP plays an important role in the metabolism of proline-containing neuropeptides, and the activity of PEP is related to the induction of neurodegenerative diseases (such as Alzheimer's disease and Parkinson's disease). Research shows that the PEP inhibitor can block the metabolism of PEP to achieve the aim of improving memory. Therefore, the PEP inhibitor can be used as a potential drug for restoring the memory of the Alzheimer disease patient to be researched.
Disclosure of Invention
The invention aims to provide a pilose antler aqueous extract with PEP inhibitory activity and application thereof. Enzymolysis products of the pilose antler aqueous extract after the action of pepsin and pancreatin have PEP inhibition activity, and can be used as a potential source for research and development of medicaments for improving cognitive impairment diseases such as Alzheimer's disease and the like.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
(1) cutting fresh pilose antler into pieces, adding deionized water with the mass 5-30 times of that of the pilose antler, heating to 90-100 ℃ (the optimal range is 95-100 ℃), stirring and extracting for 1-5 (the optimal range is 2-4) hours, cooling to room temperature after extraction is finished, filtering with a filter screen with 170-270 (the optimal range is 200-230) meshes, and obtaining the extract as filtrate.
(2) Adjusting the pH value of the extract to 1.0-5.0 (the optimal range is 1.5-2.0) by using 1-6M HCl, uniformly stirring, adding protease A with the mass of 0.1-5.0% (w/w) (the optimal range is 2.0-3.0%) of the antler, and carrying out enzymolysis for 0.5-24 hours (the optimal range is 3-10 hours) at the temperature of 20-80 ℃ (the optimal range is 30-50 ℃); adjusting the pH value to 6.0-8.0 (the optimal range is 6.5-7.5) by using 1-6M NaOH after the enzymolysis is finished, adding protease B with the mass of 0.1-5.0% (w/w) (the optimal range is 2.0-3.0%) of the antler, carrying out enzymolysis for 0.5-24 hours (the optimal range is 3-10 hours) at the temperature of 20-80 ℃ (the optimal range is 30-50 ℃), increasing the temperature to 90-100 ℃ (the optimal range is 95-100 ℃) after the reaction is finished, preserving the temperature for 10-30 minutes, and then reducing the temperature to the room temperature.
(3) Centrifuging the enzymolysis liquid at the speed of 15000 Xg-25000 Xg for 20-30 minutes at the temperature of 4-8 ℃, collecting supernatant, performing ultrafiltration for 20-30 minutes at the speed of 10000 Xg-16000 Xg by using an ultrafiltration membrane with the molecular weight cutoff of 5K-20K daltons, collecting filtrate, and freeze-drying to obtain the component with the prolyl endonuclease inhibition activity.
The proteolytic enzyme A is one or a combination of pepsin, trypsin, chymotrypsin, elastase, papain, bromelain and flavourzyme; the proteolytic enzyme B is one or more of trypsin, chymotrypsin, carboxypeptidase, papain, bromelain, flavourzyme and neutral protease. The proteolytic enzyme A and the protease B cannot be identical.
The active ingredient contains prolyl endonuclease inhibitory peptides such as LPQPPQE, GPAGPQGPR, LPPLTAD, PPGLPGSPGQ, etc.
The cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity can be used for treating or preventing cognitive disorder diseases such as Alzheimer's disease and Parkinson's disease.
The invention establishes a preparation method of the pilose antler active component with prolyl endonuclease inhibition activity, and the prepared pilose antler PEP inhibitory peptide can be applied to the prevention and treatment of cognitive impairment diseases such as Alzheimer's disease and the like, and has wide application prospect.
Compared with the prior art, the invention has the following beneficial effects:
1. the method has the advantages of high extraction rate of active components of cornu Cervi Pantotrichum, mild reaction conditions, good retention of original active components in cornu Cervi Pantotrichum, simple process, and applicability to large-scale production.
2. The basis of the active ingredients of the pilose antler is analyzed by combining the leading edge analysis technology LC-MS/MS, so that the result is more accurate and credible.
3. Has good application prospect. The invention has wide application prospect as a potential source for researching and developing cognitive disorder diseases.
Detailed Description
Example 1
The fresh sika deer antler is used as a raw material and is prepared according to the following process:
freeze drying and pulverizing fresh cornu Cervi Pantotrichum, adding 5L deionized water into 1kg of powder, heating to 100 deg.C, stirring and extracting for 5 hr, cooling to room temperature after extraction, and filtering with 200 mesh filter screen to obtain filtrate.
Adjusting pH of the extract to 2.0 with 6M HCl, stirring, adding 1g pepsin, and performing enzymolysis at 37 deg.C for 5 hr; and (3) after the enzymolysis is finished, adjusting the pH to 7.0 by using 1M NaOH, adding 1g of trypsin, carrying out enzymolysis for 5 hours at the temperature of 37 ℃, raising the temperature to 100 ℃ after the reaction is finished, preserving the temperature for 10-30 minutes, and then cooling to room temperature.
Centrifuging the above enzymolysis solution at 15000 × g speed at 4 deg.C for 30 min, collecting supernatant, ultrafiltering with ultrafiltration membrane with cut-off molecular weight of 10K Dalton at 10000 × g speed for 30 min, collecting filtrate, and freeze drying to obtain component with PEP inhibiting activity.
Detecting PEP inhibitory activity of the obtained cornu Cervi Pantotrichum fraction
1. Principle of
The PEP can specifically hydrolyze small molecular weight polypeptide at the carboxyl terminal of proline, so the method adopts Z-Gly-Pro-4-nitroanalide as a substrate of the PEP, and the yellow paranitroaniline has a characteristic absorption peak at 405nm after the Z-Gly-Pro-4-nitroanalide is cut off by the PEP, and the inhibitory activity of the sample on the PEP can be calculated according to the absorbance change at 405nm before and after the sample and the substrate are added.
2. Method of producing a composite material
(1) Sample preparation: the samples were dissolved in 10mM PBS buffer (pH 7.0) and prepared as required for the experiment as solutions at concentrations of 0.5, 1.0 and 2.0mg/mL, respectively.
(2) Substrate solution: Z-Gly-Pro-4-nitroanalide (Z-Gly-Pro-pNA) solution, and Z-Gly-Pro-4-nitroanalide is prepared into 10mM solution by using 40% (v/v) dioxane.
(3) Positive drug: sodium Valproate (Sodium Valproate) was dissolved in 10mM PBS (pH 7.0) and prepared to concentrations of 0.2, 0.4, 1.0, 2.0 and 4.0mM, respectively, as required for the experiment.
(4) Enzyme solution: PEP solution, PEP solution was prepared by diluting PEP with a protective solution (45mM Tris-HCl, pH 8.0, 124mM NaCl, 2.4mM KCl, 10% (v/v) glycerol, 225mM imidazole and 3mM DTT) to 1U/mL, storing in a freezer at-80 ℃ and diluting 8-fold with PBS (10mM PBS, 137mM NaCl and 2.7mM KCl, pH 7.0) just before use.
The assay was performed in 96-well plates and absorbance was measured at 405nm using a microplate reader. Firstly, 140 mu L of PBS, 20 mu L of sample (or buffer solution) and 20 mu L of PEP enzyme solution are sequentially added into a sample hole, incubated for 5min at 37 ℃, then 20 mu L of substrate is added, mixed uniformly and incubated for 30 min at 37 ℃, and the absorbance at 405nm is measured by a microplate reader. The total volume of the reaction was 200. mu.l. Triplicate were done per well and the sample inhibition was calculated.
TABLE 1 PEP inhibitory Activity assay Components and sample amounts
Figure BDA0001363321430000041
Note: "-" indicates no addition of any reagent.
Inhibition rate calculation formula:
Figure BDA0001363321430000042
wherein I represents the inhibition ratio, ASampleDenotes the absorbance value of the sample, ASampleblankDenotes the blank absorbance value of the sample, AControlThe absorbance values of the negative control groups, AblankIndicating blank absorbance values.
3 Positive control test results
The PEP inhibition activity of the positive control sodium valproate was determined as above when the positive control sodium valproate concentration was 0.2, 0.4, 1, 2 and 4 mM. The results are shown in table 2:
TABLE 2 Positive control sample concentration and PEP inhibition
Figure BDA0001363321430000043
Warp IC50IC for calculating sodium valproate by calculator50It was 1.98 mM.
When the concentration of the pilose antler sample is 2.0mg/mL, the PEP inhibition rate is 26.52 percent
Desalting the ultrafiltrate of the enzymolysis product of cornu Cervi Pantotrichum extract with C18-SPE column. After desalting, freeze-drying, redissolving in 0.1% (v/v) formic acid water, and mass spectrometry of the sample using LTQ Orbitrap XL (ion trap cyclotron resonance combination mass spectrometer). The peptide composition of the active ingredients of deer antler is shown in table 3.
TABLE 3 composition of peptides of the active ingredient of velvet antler
Figure BDA0001363321430000051
Figure BDA0001363321430000061
Figure BDA0001363321430000071
Figure BDA0001363321430000081
Figure BDA0001363321430000091
Figure BDA0001363321430000101
Figure BDA0001363321430000111
Figure BDA0001363321430000121
Figure BDA0001363321430000131
Figure BDA0001363321430000141
Figure BDA0001363321430000151
Figure BDA0001363321430000161
Example 2
Freeze drying and pulverizing fresh cornu Cervi Pantotrichum, adding 10L deionized water into 1kg of powder, heating to 90 deg.C, stirring and extracting for 3 hr, cooling to room temperature after extraction, and filtering with 230 mesh filter screen to obtain filtrate, i.e. cornu Cervi Pantotrichum extract.
Adjusting pH of the extract to 5.0 with 3M HCl, stirring, adding 1g pepsin, and performing enzymolysis at 50 deg.C for 3 hr; after the enzymolysis is finished, the pH value is adjusted to 8.0 by using 2M NaOH, 1g of chymotrypsin is added, the enzymolysis is carried out for 3 hours at the temperature of 50 ℃, the temperature is increased to 90 ℃ after the reaction is finished, the temperature is kept for 10 minutes, and then the temperature is reduced to the room temperature.
Centrifuging the above enzymolysis solution at 25000 × g speed at 6 deg.C for 20 min, collecting supernatant, ultrafiltering with ultrafiltration membrane with cut-off molecular weight of 15K Dalton at 15000 × g speed for 20 min, collecting filtrate, and freeze drying to obtain component with PEP inhibiting activity.
PEP inhibitory activity was detected and mass spectrometry was performed on the obtained velvet antler fraction according to the method in example 1.
When the concentration of the system is 1.0mg/mL, the PEP inhibition rate of the sample prepared by the method is 20.83%, and the components comprise main active peptides: LPQPPQE, GPAGPQGPR, LPPLTAD, PPGLPGSPGQ.
Example 3
Freeze drying and pulverizing fresh cornu Cervi Pantotrichum, adding 20L deionized water into 1kg of powder, heating to 100 deg.C, stirring for 1 hr, cooling to room temperature, and filtering with 170 mesh filter screen to obtain filtrate.
Adjusting pH of the extract to 4.0 with 2M HCl, stirring, adding 1g pepsin, and performing enzymolysis at 30 deg.C for 10 hr; adjusting pH to 6.0 with 5M NaOH, adding elastase with a mass of 1g of cornu Cervi Pantotrichum, performing enzymolysis at 30 deg.C for 10 hr, heating to 100 deg.C, holding for 20 min, and cooling to room temperature.
Centrifuging the above enzymolysis solution at 20000 × g at 8 deg.C for 30 min, collecting supernatant, ultrafiltering with ultrafiltration membrane with cut-off molecular weight of 20K Dalton at 12000 × g for 30 min, collecting filtrate, and freeze drying to obtain component with PEP inhibiting activity.
PEP inhibitory activity was detected and mass spectrometry was performed on the obtained velvet antler fraction according to the method in example 1.
When the concentration of the system is 3.0mg/mL, the PEP inhibition rate of the sample prepared by the method is 35.27%, and the components comprise main active peptides: LPQPPQE, GPAGPQGPR, LPPLTAD, PPGLPGSPGQ.
Example 4
Freeze drying and pulverizing fresh cornu Cervi Pantotrichum, adding 1kg powder into 30L deionized water, heating to 95 deg.C, stirring and extracting for 5 hr, cooling to room temperature after extraction, and filtering with 270 mesh filter screen to obtain filtrate.
Adjusting pH of the extract to 2.0 with 3M HCl, stirring, adding 1g pepsin, and performing enzymolysis at 37 deg.C for 20 hr; after the enzymolysis is finished, the pH value is adjusted to 7.0 by 6M NaOH, 0.5g of trypsin and 0.5g of chymotrypsin are added for enzymolysis at the temperature of 37 ℃ for 20 hours, and after the reaction is finished, the temperature is raised to 95 ℃ and is kept for 30 minutes, and then the temperature is reduced to the room temperature.
Centrifuging the above enzymolysis solution at 20000 × g at 4 deg.C for 30 min, collecting supernatant, ultrafiltering with ultrafiltration membrane with cut-off molecular weight of 10K Dalton at 16000 × g for 30 min, collecting filtrate, and freeze drying to obtain component with PEP inhibiting activity.
PEP inhibitory activity was detected and mass spectrometry was performed on the obtained velvet antler fraction according to the method in example 1.
When the concentration of the system is 1.0mg/mL, the PEP inhibition rate of the sample prepared by the method is 57.45%, and the components comprise main active peptides: LPQPPQE, GPAGPQGPR, LPPLTAD, PPGLPGSPGQ.

Claims (5)

1. A preparation method of cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity is characterized by: extracting cornu Cervi Pantotrichum, performing enzymolysis, and purifying to obtain cornu Cervi Pantotrichum active component with prolyl endopeptidase inhibiting activity, which comprises the following steps:
freeze drying and pulverizing fresh cornu Cervi Pantotrichum, adding 1kg powder into 30L deionized water, heating to 95 deg.C, stirring and extracting for 5 hr, cooling to room temperature after extraction, and filtering with 270 mesh filter screen to obtain filtrate (cornu Cervi Pantotrichum extract);
adjusting pH of the extract to 2.0 with 3M HCl, stirring, adding 1g pepsin, and performing enzymolysis at 37 deg.C for 20 hr; adjusting the pH value to 7.0 by using 6M NaOH after the enzymolysis is finished, adding 0.5g of trypsin and 0.5g of chymotrypsin, carrying out enzymolysis for 20 hours at the temperature of 37 ℃, raising the temperature to 95 ℃ after the reaction is finished, preserving the temperature for 30 minutes, and then cooling to the room temperature;
the enzymolysis solution is prepared with 20000gCentrifuging at 4 deg.C for 30 min, collecting supernatant, and collecting supernatant with ultrafiltration membrane with cut-off molecular weight of 10K dalton in 16000gThe mixture was ultrafiltrated at the speed of (1) for 30 minutes, and the filtrate was collected and freeze-dried to obtain a fraction having prolyl endonuclease inhibitory activity.
2. The method of claim 1, wherein: the prepared active component contains prolyl endonuclease inhibiting peptide selected from LPQPPQE, GPAGPQGPR, LPPLTAD and PPGLPGSPGQ.
3. A cornu Cervi Pantotrichum active ingredient with prolyl endonuclease inhibiting activity prepared by the preparation method of any of claims 1-2.
4. A use of the active fraction of deer antler having prolyl endonuclease inhibitory activity of claim 3, wherein: the cornu cervi pantotrichum active component with prolyl endonuclease inhibiting activity is used for preparing a medicament for treating and/or preventing nervous system diseases;
the neurological disease is a neurodegenerative disease.
5. Use according to claim 4, characterized in that: the disease is Alzheimer's disease or Parkinson's disease cognitive impairment.
CN201710628457.0A 2017-07-28 2017-07-28 Cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity, and its preparation method and application Active CN109303789B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710628457.0A CN109303789B (en) 2017-07-28 2017-07-28 Cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity, and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710628457.0A CN109303789B (en) 2017-07-28 2017-07-28 Cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity, and its preparation method and application

Publications (2)

Publication Number Publication Date
CN109303789A CN109303789A (en) 2019-02-05
CN109303789B true CN109303789B (en) 2021-10-15

Family

ID=65204920

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710628457.0A Active CN109303789B (en) 2017-07-28 2017-07-28 Cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity, and its preparation method and application

Country Status (1)

Country Link
CN (1) CN109303789B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI777448B (en) * 2021-03-10 2022-09-11 大江生醫股份有限公司 Use of bioactive compound for preparing an eye protection and/or anti-inflammatory composition
CN113499353A (en) * 2021-08-02 2021-10-15 长春中医药大学 Preparation method and application of ginseng and pilose antler refined component with anti-Alzheimer disease activity
CN113817019B (en) * 2021-09-09 2023-09-12 集美大学 Prolyl endopeptidase natural inhibitor, and preparation method and application thereof
WO2023136573A1 (en) * 2022-01-11 2023-07-20 유니메드제약주식회사 Composition for improving memory or cognition or preventing or treating cranial nerve diseases, comprising porcine brain hydrolysates

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101433188B1 (en) * 2013-08-20 2014-08-26 주식회사 삼성신약바이오 Composition For Relieving Alcohol-induced Hangover Comprising Starch, Amino Acids, Active Complex Vitamin And Oriental Herb Medicine materials AND, The Manufacturing Method Thereof
CN105769913A (en) * 2016-03-22 2016-07-20 吉林省标达科技有限责任公司 Method of extracting active substance in Cornu cervi pantotrichum
CN106349357A (en) * 2016-09-14 2017-01-25 大连理工大学 Application of pilose antler polypeptides to affecting migration of mesenchymal stem cells
CN106551391A (en) * 2015-09-25 2017-04-05 中国科学院大连化学物理研究所 A kind of pilose antler deep working method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105504010B (en) * 2014-09-24 2018-09-21 中国科学院大连化学物理研究所 A kind of polypeptide and its application with DPP-IV inhibitory activity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101433188B1 (en) * 2013-08-20 2014-08-26 주식회사 삼성신약바이오 Composition For Relieving Alcohol-induced Hangover Comprising Starch, Amino Acids, Active Complex Vitamin And Oriental Herb Medicine materials AND, The Manufacturing Method Thereof
CN106551391A (en) * 2015-09-25 2017-04-05 中国科学院大连化学物理研究所 A kind of pilose antler deep working method
CN105769913A (en) * 2016-03-22 2016-07-20 吉林省标达科技有限责任公司 Method of extracting active substance in Cornu cervi pantotrichum
CN106349357A (en) * 2016-09-14 2017-01-25 大连理工大学 Application of pilose antler polypeptides to affecting migration of mesenchymal stem cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Protein digestomic analysis reveals the bioactivity of deer antler velvet in simulated gastrointestinal digestion;Yang Yu et al.;《Food Research International》;20170405;第96卷;第183页左栏第2段、右栏第1段、第2.2节、第189页第3.2-3.3、4节、图3B、表3-4 *
乳蛋白及鹿茸蛋白消化组学的研究;于洋;《中国优秀硕士学位论文全文数据库 工业科技Ⅰ辑》;20180215(第02期);第B024-216页 *

Also Published As

Publication number Publication date
CN109303789A (en) 2019-02-05

Similar Documents

Publication Publication Date Title
CN109303789B (en) Cornu Cervi Pantotrichum active component with prolyl endonuclease inhibiting activity, and its preparation method and application
EP0893449B1 (en) Antitumor substance extracted from hen-of-the-woods
Sabbione et al. Amaranth peptides with antithrombotic activity released by simulated gastrointestinal digestion
Mohamad Ansor et al. Anti-angiotensin converting enzyme (ACE) proteins from mycelia of Ganoderma lucidum (Curtis) P. Karst
CN101584853B (en) Earthworm protein polypeptide preparation
CN111518164B (en) ACE inhibitory peptide P2, application thereof and preparation method thereof
CN112646003A (en) Sipunculus nudus ACE inhibitory peptide and preparation method and application thereof
CN106008669B (en) A kind of hazelnut ace inhibitory peptide and preparation method thereof
CN117126243B (en) Small molecular peptide PYPDW and application thereof
KR101706754B1 (en) residual product of fish protein having reduced antigencity and improved antioxidant activity
CN111057124B (en) Impurity removing method for glycyrrhetate
CN109880868B (en) Cornu Cervi Pantotrichum active component with effect of resisting oxidative stress injury of HT-22 cell induced by glutamic acid, and its preparation method and application
CN1307198C (en) Separation and purification procss of neurotoxin and cytotoxin of cobratoxin
CN106905416A (en) With active peptide for suppressing dipeptidyl peptidase 4 and preparation method and application
CN114934090B (en) Sea cucumber peptide with moisturizing effect and preparation method thereof
JP2005516043A5 (en)
RU2004123201A (en) METHOD FOR EXTRACTION, CLEANING AND ENZYMATIC MODIFICATION OF 7S-GLOBULIN SOYBEAN SUBSTITUTES α'-SUBJECT FOR USE AS A HYPOCHOLESTERINEMIC AGENT
CN116042756A (en) Preparation and application of high-activity high-safety standard sample of cardamine violifolia selenoprotein
CN111499691B (en) ACE inhibitory peptide P1, application thereof and preparation method thereof
CN111187343B (en) Peony 2S albumin and extraction method and application thereof
CN109400687B (en) ACE inhibitory peptide derived from broccoli protein, and preparation method and application thereof
CN106632632B (en) Armadillidium fibrinolytic active protein and application thereof
ES2456697T3 (en) Procedure for obtaining chondroitinsulfuric acid and its uses
CN115746095B (en) Selenium-enriched peptide with heat stress resistance activity and preparation method and application thereof
CN114088853B (en) Characteristic peptide segment of soman poisoning and identification method of soman poisoning

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant